AbSci

In silico antibody design expert Dr. Victor Greiff, synthetic biology pioneer Dr. Timothy Lu, and translational medicine veteran Dr. Hubert Truebel…

Creating antibodies in silico with generative AI represents a major industry breakthrough on the path to fully de novo antibody design and Absci’s…

Absci to present in-silico drug discovery technology at NVIDIA GTC Breakthrough ML achievements highlight the viability of the computational lead…

Biotechnology industry veterans Dr. Sarah Korman and Nikhil Goel to lead legal and business development teams Absci, the synthetic biology company…

- AbSci's approach to drug creation has the potential to disrupt conventional biologic drug discovery - Complementary technologies combined to enable…